Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2010, Triventures is a global venture capital fund based in the United States and Israel. The firm initially focused on medical devices and has since expanded into data-driven solutions across various sectors. Triventures manages a diverse portfolio and emphasizes partnerships with entrepreneurs in healthcare, fintech, cybersecurity, and e-commerce.
Triventures invests in early-stage companies at the pre-seed, seed, and Series A stages, targeting sectors such as healthcare, biotech, fintech, and cybersecurity. The firm seeks validated business models with the potential to transform their industries, particularly emphasizing bio-convergence and data-driven technologies.
Triventures has backed notable companies including 1-800 Contacts (acquired in 2019), Thoratec (acquired in 2014), Tivity Health (acquired in 2023), Medtronic (acquired in 2023), bioMérieux (acquired in 2025), Qiagen (acquired in 2025), Accolade (acquired in 2021), Johnson & Johnson (acquired in 2024), and Palo Alto Networks (acquired in 2019).
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.